Benchmarking of variant pathogenicity prediction methods using a population genetics approach

preprint OA: closed CC-BY-4.0
📄 Open PDF Full text JSON View at publisher

Abstract

Motivation Variant pathogenicity predictors are essential for identifying new associations between genetic variants and rare diseases. However, despite the availability of numerous predictors, there is no clear consensus on which methods provide the most reliable results. The common practice of training, testing, and benchmarking these predictors using known variant sets from disease or mutagenesis studies raises concerns about ascertainment bias and data circularity. Results We benchmarked commonly used pathogenicity predictors using an orthogonal approach that does not rely on predefined “ground truth” datasets. By leveraging population-level genomic data from gnomAD and the Context-Adjusted Proportion of Singletons (CAPS) metric, we identified CADD and REVEL as the best-performing predictors for distinguishing extremely deleterious variants from moderately deleterious ones. REVEL demonstrated superior calibration. Additionally, we show that CAPS can serve as a meta-analysis tool for interpreting variant annotations and highlight biases in ClinVar-based predictor training. Availability and Implementation CAPS analysis and benchmarking results are available at https://github.com/mgudVCCRI/PopGenVariantFiltering Contact [email protected]
Full text 1,659 characters · extracted from oa-doi-fallback · 2 sections · click to expand

Abstract

Motivation Variant pathogenicity predictors are essential for identifying new associations between genetic variants and rare diseases. However, despite the availability of numerous predictors, there is no clear consensus on which methods provide the most reliable results. The common practice of training, testing, and benchmarking these predictors using known variant sets from disease or mutagenesis studies raises concerns about ascertainment bias and data circularity.

Results

We benchmarked commonly used pathogenicity predictors using an orthogonal approach that does not rely on predefined “ground truth” datasets. By leveraging population-level genomic data from gnomAD and the Context-Adjusted Proportion of Singletons (CAPS) metric, we identified CADD and REVEL as the best-performing predictors for distinguishing extremely deleterious variants from moderately deleterious ones. REVEL demonstrated superior calibration. Additionally, we show that CAPS can serve as a meta-analysis tool for interpreting variant annotations and highlight biases in ClinVar-based predictor training. Availability and Implementation CAPS analysis and benchmarking results are available at https://github.com/mgudVCCRI/PopGenVariantFiltering Contact e.giannoulatou{at}victorchang.edu.au Competing Interest Statement The authors have declared no competing interest. Footnotes Congenital Heart Disease Synergy Study group: Sally L. Dunwoodie, David S. Winlaw, Eleni Giannoulatou, Natasha Nassar, Edwin P. Kirk, Gavin Chapman, Gillian M. Blue, Gary F. Sholler, Samantha J. Lain Updated Methods and Discussion, revised Figure 5 and additional Supplementary Tables.

Text is read by the "Ask this paper" AI Q&A widget below. Extraction quality varies by source — PMC NXML preserves structure cleanly, OA-HTML may include some navigation residue, and OA-PDF can have broken hyphenation. The publisher copy (via DOI) is the canonical version.

My notes (saved in your browser only)

Ask this paper AI returns verbatim quotes from the full text · source: oa-doi-fallback

Answers must be backed by verbatim quotes from this paper's full text. Hallucinated quotes are dropped automatically; if no verbatim passage answers the question, we say so. How this works

Citation neighborhood (no data yet)

We don't have any in-corpus citations linked to this paper yet. This is a recent paper (2025) — citers typically take a year or two to land, and the OpenAlex reference graph may still be filling in.

Source provenance

europepmc
last seen: 2026-05-20T01:45:00.602351+00:00
unpaywall
last seen: 2026-05-26T02:00:01.498150+00:00
License: CC-BY-4.0